Loading company…
SyntheticGestalt develops AI models for molecular design, drug discovery, and enzymes.
Based in London with operations in Japan, SyntheticGestalt develops AI models using Geometric Deep Learning to analyze and design molecules for drug discovery and enzyme applications. It works with pharmaceutical companies and academic institutions, including Shionogi & Co., Ltd. and Hokkaido University. In December 2021, it raised GBP 8 million in Series A funding as part of a larger GBP 12 million round.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in